News desk | ILLINOIS


CHAMPAIGN, Illinois – Dr. Mark S. Cohen will serve as the next dean of Carle Illinois College of Medicine and senior vice president and director of studies at Carle Health, pending approval from the University of Illinois. The appointment takes effect on May 16.

Cohen is currently Professor of Surgery and Pharmacology at the University of Michigan, where he is also Director of the Medical School Pathway of Excellence in Innovation and Entrepreneurship, Director of Endocrine Surgery Research, and Chief Innovation Officer at the Rogel Cancer Center in the University of Michigan. . He earned a bachelor’s degree in chemical engineering and an MD from Washington University in St. Louis.

“Dr. Cohen brings a clear and compelling vision of a bold and ambitious future for Carle Illinois,” said Illinois Chancellor Robert J. Jones. “This is the first college of its kind in the world, and it has already established itself as a home for innovators and trailblazers. Our next Dean embodies that same spirit. It will be exciting to watch this college progress through each phase of its mission under his leadership.”

“As a physician and engineer with extensive experience in medical education, research, and in particular expertise in developing and bringing medical advances to market, we believe that Dr. Cohen will lead Carle Illinois to his brighter and brighter future,” said James C. Leonard, MD. , President and CEO of Carle Health. “His work at Carle Illinois will result in innovations in care delivery for patients in Illinois and beyond.”

Cohen’s clinical interests and national expertise lie in the areas of endocrine surgery. He has written and published 115 original articles, 12 book chapters and a textbook on medical innovation and entrepreneurship. His research has been funded by the Susan G. Komen Foundation, the American Cancer Society, and the National Institutes of Health.

King Li, hired in 2016 as the inaugural dean of the Carle Illinois College of Medicine, announced in 2021 his intention to retire.

The world’s first engineering-based medical school, Carle Illinois College of Medicine emphasizes human factors, design thinking, medical technologies, and entrepreneurship. Established in 2015 as a partnership between the University of Illinois at Urbana-Champaign and Carle Health, Carle Illinois now has nearly 160 students and more than 600 affiliated clinical and academic faculty members.

More than 80% of college students have a background in engineering, advanced math, computer science, and other quantitative science disciplines. Courses are designed and co-directed by teams consisting of a basic scientist, a clinician and an engineer. The first class of Carle Illinois graduates will enter residency in the summer of 2022.

Source link


Comments are closed.